DoseMeRx vs PrecisePK
Two Bayesian dosing platforms with genuinely different strengths. DoseMeRx is the better engineered product at the bedside, showing the pharmacist how well the model fits this patient's measured concentrations alongside the dose, which is the disclosure that tells you when to distrust the answer, and it holds HITRUST with the clearest residency statement in the segment. PrecisePK has the longest clinical lineage in this category and the best independent comparative result, and it explains its own computation step by step rather than calling it proprietary. The gap is assurance: PrecisePK publishes no attestation, no health privacy statement and no business associate terms at all. For a hospital pharmacy that is a procurement problem regardless of how good the mathematics is.
- The interface shows how well the model fits this patient's measured concentrations alongside the recommended dose, which lets a pharmacist see when the model is struggling rather than only what it concluded.
- HITRUST certification is held and the residency disclosure is the most specific in the segment, naming the cloud provider and region.
- The widest geographic footprint in the segment, which matters for a health system operating across more than one country.
- It holds the best independent comparative result in this category, which is a stronger form of evidence than any vendor run study.
- The technology page walks a reader through the actual computation in sequence, from population model through Bayesian updating, rather than describing it as proprietary.
- The longest continuous clinical lineage of any product here, developed from a pharmacokinetics service by a pharmacist, with a sixty day evaluation offered.
Side by Side
| Axis | D DoseMeRx |
P PrecisePK |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Neither product holds a device clearance and neither claims one, which is the settled position for therapeutic drug monitoring software, so the dose these tools compute has not been reviewed by a regulator. PrecisePK publishes no security attestation, no health privacy statement and no business associate terms across two targeted passes, which is a material gap for software handling renal function, concentrations and demographics. Neither publishes performance by age, sex, race, renal function band or body habitus, and dosing models are known to perform differently across those groups.